We are live on
!
Find out more
PAWC
P.A.W. Capital Portfolio holdings
AUM
$131M
1-Year Est. Return
46.14%
This Fund
S&P 500
This Quarter
Est. Return
-7.19%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$79.7M
AUM Growth
-$14.5M
(-15%)
Cap. Flow
-$4.73M
Cap. Flow
% of AUM
-5.94%
Top 10 Holdings %
Top 10 Hldgs %
43.87%
Holding
70
New
4
Increased
16
Reduced
25
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRTU
Virtusa Corporation
VRTU
|
+$2.28M |
| 2 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
+$1.99M |
| 3 |
CTLP
Cantaloupe
CTLP
|
+$897K |
| 4 |
JPMorgan Chase
JPM
|
+$639K |
| 5 |
Microsoft
MSFT
|
+$536K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$1.62M |
| 2 |
CARB
Carbonite Inc
CARB
|
+$1.19M |
| 3 |
CLLS
Cellectis
CLLS
|
+$1.13M |
| 4 |
Ares Capital
ARCC
|
+$993K |
| 5 |
BlackRock TCP Capital
TCPC
|
+$976K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.8% |
| 2 | Healthcare | 15.92% |
| 3 | Communication Services | 14.15% |
| 4 | Consumer Staples | 10.92% |
| 5 | Industrials | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Philip Morris
PM
$309B
| $534K | 0.67% |
8,000
| – | – |
|
52
TotalEnergies
TTE
$193B
| $522K | 0.65% |
10,000
| – | – |
|
|
53
Microsoft
MSFT
$2.9T
| $508K | 0.64% |
+5,000
| New | +$536K |
|
54
New Mountain Finance
NMFC
$654M
| $503K | 0.63% |
40,000
-40,000
| -50% | -$529K |
|
55
IBM
IBM
$213B
| $455K | 0.57% |
4,184
| – | – |
|
56
Blackstone
BX
$104B
| $447K | 0.56% |
15,000
| – | – |
|
57
Weyerhaeuser
WY
$17.6B
| $437K | 0.55% |
+20,000
| New | +$533K |
|
58
Morgan Stanley
MS
$319B
| $397K | 0.5% |
+10,000
| New | +$436K |
|
59
Carlyle Group
CG
$16.1B
| $394K | 0.49% |
25,000
| – | – |
|
60
Comcast
CMCSA
$87.3B
| $341K | 0.43% |
10,000
-5,000
| -33% | -$183K |
|
|
CLLS
61
Cellectis
CLLS
$288M
| – | – |
-40,000
| Closed | -$1.13M |
|
62
Cytosorbents Corp
CTSO
$22.2M
| – | – |
-10,000
| Closed | -$129K |
|
63
Cue Biopharma
CUE
$118M
| – | – |
-2,667
| Closed | -$724K |
|
64
GE Aerospace
GE
$364B
| – | – |
-8,346
| Closed | -$452K |
|
|
LKFT
65
CALL
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| – | – |
-9,000
| Closed | -$1.01M |
|
|
66
CALL
IBM
IBM
$213B
| – | – |
-2,615
| Closed | -$378K |
|
67
Newell Brands
NWL
$2.21B
| – | – |
-15,000
| Closed | -$305K |
|
Similar funds
EIM
CIP
AC
ADEF
LC
EWP
OIM
EPI
P.A.W. Capital's Q4 2018 Portfolio in Review
As of Q4 2018, P.A.W. Capital held 70 positions worth $79.7M, down 15% from $94.2M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
P.A.W. Capital withdrew a net $4.73M in Q4 2018, closing 8 positions and reducing 25 holdings. Its most notable exit was Cellectis, an estimated $1.13M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 32% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, P.A.W. Capital opened a new position in JPMorgan Chase worth $586K.
- P.A.W. Capital's largest Q4 2018 buy was JPMorgan Chase: 6,000 shares worth $586K.
- P.A.W. Capital added most to Virtusa Corporation in Q4 2018, an estimated $2.28M increase.
- P.A.W. Capital's biggest Q4 2018 reduction was Mandiant, Inc. Common Stock, cutting an estimated $1.62M.
- P.A.W. Capital fully exited Cellectis in Q4 2018, selling an estimated $1.13M.
- P.A.W. Capital's ten largest holdings make up 44% of its $79.7M portfolio in Q4 2018.
- P.A.W. Capital opened 4 new positions and closed 8 in Q4 2018.
- P.A.W. Capital's portfolio value fell 15% quarter-over-quarter to $79.7M.
Based on P.A.W. Capital's 13F filing for Q4 2018, filed 6 Feb 2019.